Clinical Remission Figures Double For People With Rheumatoid Arthritis Following Multiple Courses Of MabThera (rituximab)

Results of the REFLEX study1 show that the number of people with rheumatoid arthritis (RA) achieving clinical remission from their disease doubled over three successive treatment courses with MabThera (rituximab) when used in combination with methotrexate (from 8.8% achieving clinical remission* after the first course to 17.6% after the third course).

More: continued here

Filed under: Arthritis on October 28th, 2008